Search Results - "García Aguado, Marcos"
-
1
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
Published in Age and ageing (01-03-2021)“…Abstract Background the coronavirus disease 2019 (COVID-19) is characterized by poor outcomes and mortality, particularly in older patients. Methods post hoc…”
Get full text
Journal Article -
2
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
Published in International journal of clinical practice (Esher) (2022)“…Background. Most evidence regarding anticoagulation and COVID-19 refers to the hospitalization setting, but the role of oral anticoagulation (OAC) before…”
Get full text
Journal Article -
3
Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis
Published in BMJ nutrition, prevention & health (01-06-2021)“…BackgroundSmoking has been associated with poorer outcomes in relation to COVID-19. Smokers have higher risk of mortality and have a more severe clinical…”
Get full text
Journal Article -
4
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis
Published in Frontiers in endocrinology (Lausanne) (30-11-2020)“…Dysnatremia is associated with increased mortality in patients with community-acquired pneumonia. SARS-COV2 (Severe-acute-respiratory syndrome caused by…”
Get full text
Journal Article -
5
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
Published in The American heart journal (01-07-2021)“…The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target…”
Get full text
Journal Article -
6
Sacubitril/Valsartan in Daily Clinical Practice: Data From a Prospective Registry
Published in Journal of cardiovascular pharmacology (01-02-2019)“…Sacubitril/valsartan (SV) is a new therapy in heart failure with reduced ejection fraction. Our aim was to determine the efficacy and safety of this drug daily…”
Get full text
Journal Article -
7
Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry
Published in Journal of cellular and molecular medicine (01-05-2022)“…Although numerous patient‐specific co‐factors have been shown to be associated with worse outcomes in COVID‐19, the prognostic value of thalassaemic syndromes…”
Get full text
Journal Article -
8
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID‐19
Published in Journal of hospital medicine (01-06-2021)“…Gender‐related differences in COVID‐19 clinical presentation, disease progression, and mortality have not been adequately explored. We analyzed the clinical…”
Get full text
Journal Article -
9
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Published in Critical care medicine (01-06-2021)“…No standard therapy, including anticoagulation regimens, is currently recommended for coronavirus disease 2019. Aim of this study was to evaluate the efficacy…”
Get full text
Journal Article -
10
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases
Published in Archivos de bronconeumología (English ed.) (01-04-2021)“…Patients with pre-existing respiratory diseases in the setting of COVID-19 may have a greater risk of severe complications and even death. A retrospective,…”
Get full text
Journal Article -
11
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart
Published in Clinical and experimental medicine (01-05-2021)“…There is limited information on the presenting characteristics, prognosis, and therapeutic approaches of young patients hospitalized for coronavirus disease…”
Get full text
Journal Article -
12
Clinical Profile of a Nonselected Population Treated With Sacubitril/Valsartan Is Different From PARADIGM-HF Trial
Published in Journal of cardiovascular pharmacology (01-08-2018)“…Our aim is to describe the characteristics of the patients receiving sacubitril/valsartan (SV) in daily clinical practice. This is a prospective registry in 10…”
Get full text
Journal Article -
13
Sex Influence on the Efficacy and Safety of Sacubitril/Valsartan
Published in Cardiology (01-01-2019)“…Women are underrepresented in sacubitril/valsartan (SV) clinical trials. The aim of this study was to assess sex-specific differences in efficacy,…”
Get more information
Journal Article -
14
Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
Published in Cardiology (01-05-2020)“…A significant number of heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) experience ventricular function recovery during…”
Get more information
Journal Article -
15
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry
Published in Journal of the American Heart Association (05-07-2022)“…Background COVID‐19 is an infectious illness, featured by an increased risk of thromboembolism. However, no standard antithrombotic therapy is currently…”
Get full text
Journal Article -
16
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry
Published in Revista española de cardiologia (01-07-2021)“…Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2. Atrial fibrillation (AF) is common in acute situations, where…”
Get full text
Journal Article -
17
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
Published in Infection (01-08-2021)“…Olfactory and gustatory dysfunctions (OGD) are a frequent symptom of coronavirus disease 2019 (COVID-19). It has been proposed that the neuroinvasive potential…”
Get full text
Journal Article -
18
Clinical profile and predictors of in-hospital mortality among older patients admitted for COVID-19
Published in Age and ageing (17-11-2020)Get full text
Journal Article -
19
-
20
Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort
Published in Revista española de geriatría y gerontología (01-03-2020)“…HF elderly patients are underrepresented in Sacubitril/Valsartan HF trials, and the effect of S/V in real-life patients with advanced age is unknown. The aim…”
Get full text
Journal Article